Literature DB >> 18170732

RETINOPATHY DURING CHLOROQUINE THERAPY.

W Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1961        PMID： 18170732      PMCID： PMC510997          DOI： 10.1136/bjo.45.11.756

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Disturbances of pigmentation with chloroquine.

Authors:  J L DALL; J A KEANE
Journal:  Br Med J       Date:  1959-05-30

2.  Corneal complication of chloroquine (aralen) phosphate therapy.

Authors:  R W ZELLER; D DEERING
Journal:  J Am Med Assoc       Date:  1958-12-27

3.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

4.  The treatment of polymorphic light eruptions with chloroquine.

Authors:  J V CHRISTIANSEN; H BRODTHAGEN
Journal:  Br J Dermatol       Date:  1956-06       Impact factor: 9.302

5.  The toxicity of chloroquine in hepatic amoebiasis in Africans.

Authors:  J WILKINSON
Journal:  East Afr Med J       Date:  1953-10

6.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

7.  Corneal epithelial changes occurring during chloroquine (aralen) therapy.

Authors:  L L CALKINS
Journal:  AMA Arch Ophthalmol       Date:  1958-12
  7 in total
  2 in total

1.  Neurotoxic effects of chloroquine in vitro.

Authors:  A Bruinink; G Zimmermann; F Riesen
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Ocular Complications of Treatment with Chloroquine and Related Antimalarial Drugs.

Authors: 
Journal:  Can Med Assoc J       Date:  1963-03-09       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.